2023/10/26 by Gyða Björnsdóttir, Mona Ameri Chalmer, Lilja Stefánsdóttir +90 · 1 voice
Medicine · Neuroscience · Biochemistry, Genetics and Molecular Biology · #Migraine and Headache Studies #Neurological Disorders and Treatments #Amino Acid Enzymes and Metabolism
paper · pdf · doi:10.1038/s41588-023-01538-0
openalex publication_date 2023/10/26 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/03
Migraine is a complex neurovascular disease with a range of severity and symptoms, yet mostly studied as one phenotype in genome-wide association studies (GWAS). Here we combine large GWAS datasets from six European populations to study the main migraine subtypes, migraine with aura (MA) and migraine without aura (MO). We identified four new MA-associated variants (in PRRT2, PALMD, ABO and LRRK2) and classified 13 MO-associated variants. Rare variants with large effects highlight three genes. A rare frameshift variant in brain-expressed PRRT2 confers large risk of MA and epilepsy, but not MO. A burden test of rare loss-of-function variants in SCN11A, encoding a neuron-expressed sodium channel with a key role in pain sensation, shows strong protection against migraine. Finally, a rare variant with cis-regulatory effects on KCNK5 confers large protection against migraine and brain aneurysms. Our findings offer new insights with therapeutic potential into the complex biology of migraine and its subtypes.